<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00575302</url>
  </required_header>
  <id_info>
    <org_study_id>Study 300 versus 450</org_study_id>
    <nct_id>NCT00575302</nct_id>
  </id_info>
  <brief_title>Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age</brief_title>
  <official_title>Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Chretien</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>EMD Serono</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Chretien</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In In vitro fertilization (IVF) treatment, poor responder patients of more than 38 years old
      are randomized prospectively into two dosages of gonadotrophins. The outcome of treatment
      will be analyzed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women &gt; 38 years, who had an insufficient response to stimulation with regular (for age)
      posology of 225 IU of gonadotrophins (urinary or recombinant), in an agonist protocol will be
      randomized prospectively into 2 groups:

      300 IU versus 450 IU of Gonal-f® administered in a short agonist protocol. Insufficient
      response is defined as: development of ≤ 4 mature follicles (of ≥ 16 mm) at time of hCG
      administration.

      Patient can be eligible for several cycles in same protocol.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    36 cases were included and the 4 centers and they are unable to increase their recruitment to
    obtain the 400 cases necessary to reach statistical significance.
  </why_stopped>
  <start_date>December 2007</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of mature oocytes</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>follicular development</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fertilization rate</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>implantation rate</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>embryo quality</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pregnancy rate</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>300</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>administration of 300 IU Gonal-f® in a short agonist protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>450</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>administration of 450 IU Gonal-f® in a short agonist protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gonal-f®: follitropin alpha</intervention_name>
    <description>Gonal-f®: follitropin alpha, administration of 300 U</description>
    <arm_group_label>300</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gonal-f®: follitropin alpha</intervention_name>
    <description>Gonal-f®: follitropin alpha, administration of 450 U</description>
    <arm_group_label>450</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women &gt; 38 years with insufficient response to stimulation with 225 IU of
             gonadotrophins (urinary or recombinant), in an agonist protocol.

          -  Insufficient response is defined as: development of ≤ 4 mature follicles (of ≥ 16 mm)
             at time of hCG administration.

          -  Patient can be eligible for several cycles in same protocol.

        Exclusion Criteria:

          -  Patients who already received doses &gt; 225 IU

          -  Patients older than 42 years

          -  Patients with basal FSH concentrations ≥ 15 mU/ml at day 3
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>38 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annick Delvigne, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHC Saint-Vincent</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHC Saint-Vincent</name>
      <address>
        <city>Rocourt</city>
        <state>Liège</state>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Saint-Pierre</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IMEC</name>
      <address>
        <city>Brussels</city>
        <zip>1180</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Gent</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2007</study_first_submitted>
  <study_first_submitted_qc>December 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2007</study_first_posted>
  <last_update_submitted>April 12, 2010</last_update_submitted>
  <last_update_submitted_qc>April 12, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>Annick Delvigne</name_title>
    <organization>CHC Saint-Vincent</organization>
  </responsible_party>
  <keyword>IVF</keyword>
  <keyword>poor responder</keyword>
  <keyword>recFSH</keyword>
  <keyword>Fertilization in Vitro</keyword>
  <keyword>Poor responders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Follicle Stimulating Hormone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

